Search Results
Jul 23, 2026, 03:27 ET Nordic Capital announces agreement to sell ArisGlobal to Dassault Systèmes, following its transformation into a scaled and AI-enabled life sciences platform
https://news.cision.com/nordic-capital/r/nordic-capital-announces-agreement-to-sell-arisglobal-to-dassault-systemes--following-its-transforma,c4376982The following files are available for download:
More news about: Nordic Capital
Jul 23, 2026, 03:24 ET Nordic Capital announces agreement to sell ArisGlobal to Dassault Systèmes, following its transformation into a scaled and AI-enabled life sciences platform
https://news.cision.com/nordic-capital/r/nordic-capital-announces-agreement-to-sell-arisglobal-to-dassault-systemes--following-its-transforma,c4376982The following files are available for download:
More news about: Nordic Capital
Jul 23, 2026, 03:00 ET Kavalan Named 'Whisky of the Year' For Second Year Running at IWC 2026
Year:Kavalan Peatist Oloroso Sherry Cask Single Cask Strength Single Malt WhiskyMaster Distiller of the Year:Zerose Yang - Head of R&DAvailability: Kavalan Peatist Oloroso Sherry Cask is available now in Taiwan and selected international markets, including France, Canada,
More news about: Kavalan Whisky
Jul 23, 2026, 03:00 ET Kavalan élu Whisky de l'année pour la deuxième année consécutive lors de l'IWC 2026
Peatist Oloroso Sherry Cask Single Cask Strength Single Malt WhiskyMaître distillateur de l'année : Zerose Yang - Chef de la R&DDisponibilité : le Kavalan Peatist Oloroso Sherry Cask est désormais disponible à Taïwan et sur certains marchés internationaux, notamment
More news about: Kavalan Whisky
Jul 23, 2026, 02:56 ET UPM Half Year Financial Report 2026: Improved second quarter results in all businesses and portfolio change progressing
https://news.cision.com/upm-kymmene-oyj/r/upm-half-year-financial-report-2026--improved-second-quarter-results-in-all-businesses-and-portfolio,c4377000The following files are available for download:
More news about: UPM-Kymmene Oyj
Jul 23, 2026, 02:37 ET Stora Enso Half-year Report 2026: Optimising our portfolio and driving results through our own actions
employees and our sales in 2025 were EUR 9.3 billion. Stora Enso shares are listed on Nasdaq Helsinki Oy (STEAV, STERV) and Nasdaq Stockholm AB (STE A, STE R). In addition, the shares are traded in the USA on OTC Markets (OTCQX) as ADRs and ordinary shares (SEOAY, SEOFF, SEOJF).
More news about: Stora Enso Oyj
Jul 23, 2026, 02:29 ET Stora Enso Half-year Report 2026: Optimising our portfolio and driving results through our own actions
employees and our sales in 2025 were EUR 9.3 billion. Stora Enso shares are listed on Nasdaq Helsinki Oy (STEAV, STERV) and Nasdaq Stockholm AB (STE A, STE R). In addition, the shares are traded in the USA on OTC Markets (OTCQX) as ADRs and ordinary shares (SEOAY, SEOFF, SEOJF).
More news about: Stora Enso Oyj
Jul 23, 2026, 02:19 ET Scania Performance Summary April - June 2026
truck deliveries, a favourable product mix, continued cost efficiencies and the growing services business. These factors more than offset increased R&D investments and the expenses related to the ramp-up of Scania's industrial hub in China.Truck order intake increased significantly, mainly driven
More news about: Scania
Jul 23, 2026, 02:18 ET Invitation to attend Systemair AB's (publ) AGM
https://news.cision.com/systemair-ab/r/invitation-to-attend-systemair-ab-s--publ-,c4376872The following files are available for download:
More news about: Systemair AB
Jul 23, 2026, 02:08 ET Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH
in R&D and innovation.Guided by its innovation and globalization strategy and supported by the strong innovation ecosystem and biopharmaceutical industry environment in Sichuan Province and Chengdu, Haisco continues to increase investment in innovation. The company has built an R&D team
More news about: Haisco Pharmaceutical Group Co., Ltd.
Jul 23, 2026, 02:00 ET Venus Medtech Announces Completion of Patient Enrollment in Pivotal China Trial for Venus-PowerX, the World's First Fully Recoverable Self-Expanding Dry-Valve TAVR System
developed a comprehensive product pipeline covering all four heart valves — TAVR, TPVR, TMVR, and TTVR —and related accessory products. With global R&D centers in China, the United States, and Israel, the company is committed to providing effective treatment solutions for life-threatening diseases.
More news about: Venus Medtech (Hangzhou) Inc.
Jul 23, 2026, 02:00 ET Venus Medtech annonce la fin du recrutement des patients dans le cadre de l'essai clinique décisif mené en Chine sur le Venus-PowerX, le premier système TAVR au monde à valve sèche auto-expansible et entièrement récupérable
produits couvrant les quatre valves cardiaques, TAVR, TPVR, TMVR et TTVR, et les produits accessoires connexes. Disposant de centres mondiaux de R&D en Chine, aux États-Unis et en Israël, la société s'engage à fournir des solutions de traitement efficaces pour les maladies mortelles.
More news about: Venus Medtech (Hangzhou) Inc.
Jul 23, 2026, 01:05 ET PLATINUM EQUITY AND NESTLÉ TO CREATE PERANEL, A $5.6 BILLION LEADER IN WATER AND PREMIUM BEVERAGES
will have full flexibility to invest in its brands and pursue growth opportunities across its global portfolio. The business includes an in-house R&D team that has contributed to approximately 120 launches since 2022, with a robust pipeline of new products in development."We are investing
More news about: Platinum Equity
Jul 23, 2026, 00:01 ET GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB
pharmaceutical companies, the Gates Foundation, Wellcome, and the United Nations Development Programme (UNDP). The GHIT Fund invests in and manages an R&D portfolio of development partnerships aimed at addressing neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases, which
More news about: GHIT Fund
Jul 23, 2026, 00:01 ET GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB
pharmaceutical companies, the Gates Foundation, Wellcome, and the United Nations Development Programme (UNDP). The GHIT Fund invests in and manages an R&D portfolio of development partnerships aimed at addressing neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases, which
More news about: GHIT Fund
Jul 22, 2026, 23:00 ET InfiMotion Technology Makes Public Debut, Showcasing Full-Stack E‑Drive Capabilities at Wuxi Event
automakers, and we are now ready to stand on our own as a trusted partner for the wider market."Cloud-Synced Global R&D: Engineering Without BordersInfiMotion's R&D network spans Wuxi, Shanghai, Ningbo, Hangzhou, and Gothenburg, with over 1,000 engineers – including a Swedish team
More news about: INFIMOTION
Jul 22, 2026, 22:38 ET InfiMotion Technology Makes Public Debut, Showcasing Full-Stack E‑Drive Capabilities at Wuxi Event
automakers, and we are now ready to stand on our own as a trusted partner for the wider market."Cloud-Synced Global R&D: Engineering Without BordersInfiMotion's R&D network spans Wuxi, Shanghai, Ningbo, Hangzhou, and Gothenburg, with over 1,000 engineers – including a Swedish team
More news about: INFIMOTION
Jul 22, 2026, 21:30 ET Mixx Technologies Acquires Sophic Silicon Technologies and Announces Manufacturing Collaboration with Kaynes Semicon
CMOS process design, EDA and IP development, and high-speed networking, will join Mixx's core product development organization and continue expanding R&D operations in India."Sophic Silicon exists because optical connectivity at hyperscale demands more – lower power, higher bandwidth, seamless
More news about: Mixx Technologies, Inc
Jul 22, 2026, 20:10 ET 歌禮宣佈將在第62屆歐洲糖尿病研究協會（EASD）年會上以口頭討論形式匯報ASC36_35 FDC減重效果優於eloralintide聯合tirzepatide的臨床前數據
簡短口頭討論細節摘要標題：ASC36與ASC35復方制劑，每月一次給藥的胰澱素受體激動劑和GLP-1R/GIPR雙靶點激動劑，在DIO大鼠中顯示出優於eloralintide聯合tirzepatide的減重效果（Co-formulation of ASC36 and ASC35, once-monthly amylin receptor agonist and GLP-1R/GIPR agonist, demonstrated superior weight
More news about: 歌禮製藥有限公司
Jul 22, 2026, 20:10 ET Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting
molecule GLP-1R agonist designed to be administered once daily orally and once monthly to once quarterly subcutaneously as a treatment therapy and a maintenance therapy for chronic weight management; ASC36, an amylin receptor peptide agonist, ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual
More news about: Ascletis Pharma Inc.
Jul 22, 2026, 20:00 ET JINRO prezentuje pierwszą globalną kampanię „Moje ulubione JINRO" z V z BTS
codziennych chwil z JINROSEUL, Korea Południowa, 23 lipca 2026 r. /PRNewswire/ -- JINRO, największa na świecie marka soju, zaprezentowała swoją pierwszą globalną kampanię zatytułowaną „Moje ulubione JINRO", której
More news about: hitejinro
Jul 22, 2026, 19:51 ET Republic of Honduras Announces Final Results of Tender Offer and Aggregate Principal Amount of Tenders Accepted for Purchase
Rule 144A Common Code: 155344334Regulation S CUSIP: P5178R AC2Regulation S ISIN: USP5178RAC27Regulation
More news about: Republic of Honduras
Jul 22, 2026, 19:05 ET El nuevo modelo Tundra 2027 de Toyota se estrena con un diseño robusto y renovado, tecnología innovadora y el nuevo paquete Trailhunter
SR5 y diseñado para clientes que buscan un rendimiento mejorado en las carreteras desde fábrica. Este paquete incluye neumáticos Michelin LTX Trail 265/70R18, suspensión mejorada de Old Man Emu, ganchos de rescate delanteros y protección adicional en los bajos para facilitar el desplazamiento sobre los
More news about: Toyota Motor North America
Jul 22, 2026, 18:46 ET GRUPO COMERCIAL CHEDRAUI, S.A.B. DE C.V. SECOND QUARTER 2026 RESULTS
https://callme.viavid.com/viavid/?callme=true&passcode=13731734&h=true&info=company&r=true&B=6Webcast
More news about: Grupo Comercial Chedraui, S.A.B. de C.V.
Jul 22, 2026, 17:36 ET /C O R R E C T I O N -- Pearlstone Partners/
More news about: Pearlstone Partners